0001144204-16-119324.txt : 20160815 0001144204-16-119324.hdr.sgml : 20160815 20160815151824 ACCESSION NUMBER: 0001144204-16-119324 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 33 CONFORMED PERIOD OF REPORT: 20160630 FILED AS OF DATE: 20160815 DATE AS OF CHANGE: 20160815 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IHO-AGRO INTERNATIONAL INC. CENTRAL INDEX KEY: 0001635538 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-MISCELLANEOUS NONDURABLE GOODS [5190] IRS NUMBER: 981191860 STATE OF INCORPORATION: NV FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-55653 FILM NUMBER: 161832158 BUSINESS ADDRESS: STREET 1: 3101 PORTOFINO PT. STREET 2: UNIT 04 CITY: COCONUT CREEK STATE: FL ZIP: 33066 BUSINESS PHONE: 4165285868 MAIL ADDRESS: STREET 1: 3101 PORTOFINO PT. STREET 2: UNIT 04 CITY: COCONUT CREEK STATE: FL ZIP: 33066 10-Q 1 v446597_10q.htm FORM 10-Q

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

FORM 10-Q

 

xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended: June 30, 2016

 

OR

 

¨TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from __________ to___________ 

 

Commission File Number: 000-55653

 

IHO-AGRO INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)

 

Nevada   98-1191860
(State or other jurisdiction
of incorporation or organization)
  (I.R.S. Employer
Identification No.)

 

3101 Portofino Point, Unit 04, Coconut Creek, FL 33066

(Address of principal executive offices)

 

(416) 854-2433

(Registrant's telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for at the past 90 days. Yes ¨ No x

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ¨   No x

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer  ¨ Accelerated filer ¨
Non-accelerated filer  ¨ Smaller reporting company x

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock: As of August 15, 2016, there were 34,959,002 shares, $0.0001 par value per share, of common stock outstanding.

 

 

 

 

 

 

IHO-Agro International, Inc.

Form 10-Q

For the Quarterly Period Ended June 30, 2016

 

Table of Contents

 

PART I – FINANCIAL INFORMATION  
     
ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)  3
     
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 9
     
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 11
     
ITEM 4. CONTROLS AND PROCEDURES  12
     
PART II – OTHER INFORMATION  
     
ITEM 1. LEGAL PROCEEDINGS  13
     
ITEM 1A. RISK FACTORS   13
     
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS  13
     
ITEM 3. DEFAULTS UPON SENIOR SECURITIES  13
     
ITEM 4. MINE SAFETY DISCLOSURES 13
     
ITEM 5. OTHER INFORMATION   13
     
ITEM 6. EXHIBITS  13

 

 

 2 

 

   

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

The Company’s unaudited interim consolidated financial statements for the three and nine month periods ended June 30, 2016 and for the comparable periods in the prior year form part of this quarterly report. They are prepared in accordance with United States generally accepted accounting principles.

 

 

IHO-Agro International Inc.

 

June 30, 2016

(Expressed in U.S. dollars)

(Unaudited)

 

  Index
   
Balance Sheets (Unaudited) 4
Statements of Operations (Unaudited) 5
Statements of Cash Flows (Unaudited) 6
Notes to the Unaudited Financial Statements 7

 

 3 

 

 

IHO-Agro International Inc.

Balance Sheets

(Expressed in U.S. dollars)

(Unaudited)

 

   June 30,
2016
$
  

September 30,
2015

$

 
         
ASSETS          
Current Assets          
Cash   3,313    33,753 
Accounts receivable   41,225    11,076 
Prepaid expenses with related party   50,368    70,433 
           
Total current assets   94,906    115,262 
           
Equipment, net of accumulated depreciation   1,275    1,913 
           
Total Assets   96,181    117,175 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
Accounts payable and accrued liabilities   12,093    15,750 
Due to shareholders   31,238    6,185 
           
Total Current Liabilities   43,331    21,935 
           
           
Stockholders’ Equity          
Common stock, 40,000,000 shares authorized, $0.0001 par value, 34,959,002 shares issued and outstanding (September 30, 2015 - 34,409,002 shares)   3,496    3,441 
Additional paid-in capital   714,963    550,018 
Accumulated deficit   (665,609)   (458,219)
           
Total Stockholders’ Equity   52,850    95,240 
           
Total Liabilities and Stockholders’ Equity   96,181    117,175 

 

See accompanying notes to unaudited financial statements.

  

 4 

 

 

IHO-Agro International Inc.

Statements of Operations

(Expressed in U.S. dollars)

(Unaudited)

 

   Three Months Ended
June 30,
  

Nine Months Ended

June 30,

 
   2016   2015   2016   2015 
   $   $   $   $ 
                 
Revenue, net   -    2,397    58,556    2,397 
                     
Operating Expenses:                    
General and administrative   155,658    63,289    265,946    176,581 
                     
Total Operating Expenses   155,658    63,289    265,946    176,581 
                     
Net Loss   (155,658)   (60,892)   (207,390)   (174,184)
                     
                     
Net Loss Per Share, Basic and Diluted   (0.00)   (0.00)   (0.00)   (0.01)
                     
Weighted Average Shares Outstanding, Basic and Diluted   35,244,716    34,624,878    34,529,987    33,695,207 

 

See accompanying notes to unaudited financial statements.

  

 5 

 

 

IHO-Agro International Inc.

Statements of Cash Flows

(Expressed in U.S. dollars)

(Unaudited)

 

    Nine Months Ended June 30,  
    2016     2015  
    $     $  
             
Operating Activities                
Net loss     (207,390 )     (174,184 )
Adjustments to reconcile net loss to net cash used in operating activities:                
   Depreciation     638       425  
   Stock-based compensation     120,000       16,426  
     Changes in operating assets and liabilities                
       Prepaid expenses with related party     20,065       (70,249 )
       Accounts receivable     (30,149 )     (7,876 )
       Accounts payable and accrued liabilities     (3,657 )     1,900  
       Due to shareholder     19,563       (15,781 )
Net Cash Used In Operating Activities     (80,930 )     (249,339 )
                 
Investing Activities                
Purchase of equipment     -       (2,550 )
Net Cash Used In Investing Activities     -       (2,550 )
                 
Financing Activities                
Proceeds from note payable to related party     10,990       -  
Payments on note payable to related party     (5,500 )     -  
Proceeds from common stock issued or subscribed     45,000       42,495  
Net Cash Provided By Financing Activities     50,490       42,495  
                 
Net Increase (Decrease) in Cash     (30,440 )     (209,394 )
Cash, Beginning of Period     33,753       275,984  
Cash, End of Period     3,313       66,590  
                 
Supplemental Disclosures:                
Interest paid            
Income taxes paid            

  

See accompanying notes to unaudited financial statements.

 

 6 

 

 

   

IHO-Agro International Inc.

Notes to the Financial Statements

June 30, 2016

(Expressed in U.S. dollars)

(Unaudited)

 

1.Basis of Presentation

 

IHO-Agro International Inc. (the “Company”) was incorporated under the laws of the State of Nevada, U.S. on July 29, 2014. The Company’s principal business is the marketing and distribution of all natural mineral based fertilizers. The Company has limited operations. Since inception through June 30, 2016, the Company has generated $62,118 in revenue, net, and has accumulated losses of $665,609.

 

The interim unaudited financial statements as of June 30, 2016, and for the three and nine months ended June 30, 2016 and 2015, have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information on the same basis as the annual financial statements and in the opinion of management, reflect all adjustments, which include only normal recurring adjustments necessary to present fairly the Company's financial position, results of operations and cash flows for the periods shown. The results of operations for such periods are not necessarily indicative of the results expected for a full year or for any future period. They do not include all of the information and footnotes required by GAAP for complete financial statements. Therefore, these financial statements should be read in conjunction with the Company's audited financial statements and notes thereto for the year ended September 30, 2015 filed in a Form 10-K.

 

During the nine months ended June 30, 2016, 99.9% of the Company’s revenue was generated from a single customer. 85.6% of the accounts receivable as of June 30, 2016 was from this single customer. 100% of the accounts receivable as of September 30, 2015 was from a single customer.

 

All fertilizer to fulfill customer orders is manufactured and shipped by a single related party vendor, Industrias y Manufacturas Bionaturales S.A., which is owned by the Company’s sole officer and sole director.

 

Going Concern

 

The financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company has generated minimal revenue since its inception and losses are anticipated in the development of its business. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

 

The ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management intends to finance operating costs over the next twelve months with existing cash on hand, accounts receivables due, and private placement of common stock. Our success is dependent upon commercializing our product and our ability to obtain adequate future financing. There can be no assurance that we will be able to obtain future financing or, if obtained, what the terms of such future financing may be, or that any amount that we are able to obtain will be adequate to support our working capital requirements until we achieve profitable operations. The financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern.

 

 7 

 

 

  

2.Equipment

 

Equipment is stated at cost and is depreciated over their estimated useful lives on a three-year straight-line basis.

 

   Cost   Accumulated
Depreciation
   June 30, 2016 
Net Carrying 
Value
   September 30, 2015 
Net Carrying
Value
 
Computer Equipment  $2,550   $1,275   $1,275   $1,913 

  

3.Related Party Transactions

 

  (a) Accounts payable as of June 30, 2016 includes $2,050 (September 30, 2015 - $1,150) of rent owed to a shareholder for the offices of the Company.

 

  (b) As of June 30, 2016, the Company had a balance of $5,490 owing to a significant shareholder for a shareholder loan. The loan is unsecured, due on demand and bears no interest.

 

  (c) As of June 30, 2016, the company also had a balance of $1,748 owed to another significant shareholder for reimbursement of company expenses paid on its behalf.

 

  (d)

The Company entered into a management consulting agreement with the Company’s sole officer and director which commenced on July 29, 2014 for consulting and other services in support of the business operations. Pursuant to the agreement, the Company paid $2,500 per month for the first two months and $6,000 per month thereafter. In addition, the Company’s sole officer and director receives a $1,000 monthly car allowance. As of June 30, 2016, there is a balance of $24,000 (September 30, 2015 - $0) owed for these services.

 

  (e)

All fertilizer shipped to customers was manufactured and shipped by a Panamanian entity called Industrias y Manufacturas Bionaturales S.A., which is owned by the Company's sole officer and director. The Company shall pay Industrias y Manufacturas Bionaturales S.A. a license fee of $5,000 per year and 5% of all sub-licensing revenue. The Company makes advance payments to this entity to cover future sales orders. As of June 30, 2016, the aggregate prepaid balance to this related party was $50,368 (September 30, 2015 - $70,433), after a $47,628 reduction for cost of goods sold on sales during the nine months ended June 30, 2016.

 

4.Common Stock

 

The Company has 40,000,000 common shares authorized with a par value of $ 0.0001 per share.

 

In November 2015 and December 2015, the Company issued an aggregate of 15 units for total proceeds of $45,000. Each unit consisted of 10,000 common shares and 5,000 share purchase warrants. Each whole share purchase warrant is exercisable at $0.60 per common share until the one-year anniversary of the first day that the common stock is traded on the OTCQB marketplace.

 

During the quarter ended June 30, 2016, the Company had the following issuances:

 

a)In April 2016, the company issued 400,000 shares of common stock for service valued at 0.30 per common share.

 

 8 

 

 

5.Share Purchase Warrants

 

Each Selling Shareholder has a warrant to purchase up to 50% of the shares owned with an exercise price of $0.60 per shares with the warrant termination on the one-year anniversary of the first day that the Common Stock is traded on the OTCQB marketplace.

 

A summary of the changes in the Company’s common share purchase warrants is presented below:

 

    Number     Weighted Average
Exercise Price
Balance September 30, 2015     617,525     $ 0.6
Issued     75,000       0.6
Balance June 30, 2016     692,525     $ 0.6

 

As at June 30, 2016, the following common share purchase warrants were outstanding and exercisable:

 

Number of
Warrants
Exercise Price Expiry Date
     
692,525 $ 0.60 One year from the first day that the Common Stock is traded on the OTCQB marketplace

  

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

 

Forward-Looking Statements

 

This Quarterly Report on Form 10-Q contains forward-looking statements. For this purpose, any statements contained in this Report that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking information includes statements relating to future actions, prospective products, future performance or results of current or anticipated products, sales and marketing efforts, costs and expenses, interest rates, outcome of contingencies, financial condition, results of operations, liquidity, business strategies, cost savings, objectives of management, and other matters. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “will,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “continue” or the negative of these similar terms. The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for forward-looking information to encourage companies to provide prospective information about themselves without fear of litigation so long as that information is identified as forward-looking and is accompanied by meaningful cautionary statements identifying important factors that could cause actual results to differ materially from those projected in the information.

 

These forward-looking statements are not guarantees of future performance and involve risks, uncertainties and assumptions that we cannot predict. In evaluating these forward-looking statements, you should consider various factors, including the following: (a) those risks and uncertainties related to general economic conditions, (b) whether we are able to manage our planned growth efficiently and operate profitable operations, (c) whether we are able to generate sufficient revenues or obtain financing to sustain and grow our operations, (d) whether we are able to successfully fulfill our primary requirements for cash, which are explained below under “Liquidity and Capital Resources”. We assume no obligation to update forward-looking statements, except as otherwise required under the applicable federal securities laws.

 

 9 

 

 

 Overview.

 

The Company was organized under the laws of the State of Nevada on July 29, 2014 and is a marketer and distributor of very unique all natural mineral based fertilizers. We do not produce the fertilizer. The Company strives to be environmentally friendly in the production of a fertilizer that we believe will reduce the worldwide dependence on chemical fertilizers and provide a safe and healthy alternative to help in the worldwide production of food.

 

In the fertilization process, there are more than 60 different minerals present in plant tissue. Farmers are well aware of the consequences of low levels of minerals in pastures, which is why animal feed is enriched with minerals. In most cases, the elements needed by a plant are also needed by animals. There are seven minerals needed in the diet of animals, and they are iron, copper, zinc, manganese, iodine, cobalt and selenium. If these elements are not present, the health of the animal is affected through slower development and depressed immune systems.

 

From inception to June 30, 2016, the Company had been undertaking development stage activities including the ongoing registration and certification of the product in various jurisdictions and countries, testing and lab work, travel and advertising, procuring agreements with qualified distribution and sales partners, accounting and administration work and production and manufacturing design.

 

The Company’s results of operations are affected by the following factors and/or circumstances: the dependence on its sole officer and director to manage operation requirements in a timely and efficient manner. This is somewhat offset by the assistance of other consulting personnel.

 

The Company’s financial condition is affected by the following factors and/or circumstances: the delay and/or inability to obtain product registration and certification in certain jurisdictions and countries that could delay or negate potential revenue. The inability to procure adequate quantities of product from the manufacturer or in a timely manner. Market conditions that would erode the selling price of fertilizer in the open market due to competition, supply and demand and increased input/raw material costs.

 

The following events and uncertainties will have the following impact on future activities; Market conditions that would erode the selling price of fertilizer in the open market due to competition, supply and demand and increased input/raw material costs. The financial condition of the manufacturer could prevent its supply of product to the company.

 

Results of Operations

 

For the three months ended June 30th, 2016 versus June 30th, 2015

 

Revenue

 

The Company recognized $-0- revenue during the three months ended June 30, 2016, comparable with $2,397 sales from the same period last year.

 

Operating Expenses

 

During the three months ended June 30, 2016 and 2015, we incurred total operating expenses of $155,658 and $63,289, respectively. This decrease was mainly due to streamlining of operations and administrative cost savings in the areas of advertising, branding and marketing,legal and professional fees, registration and filing fees, equipment rentals, and business travel. Further, a consulting expense for marketing and sales efforts in the form of stock-based compensation totaled $120,000 during the quarter versus nil in the same period last year.

 

Net Loss

 

During the three months ended June 30, 2016 and 2015, we incurred a net loss of $155,658 and $60,892, respectively, an increase of $94,766. This increase was due mainly to streamlining of operations and administrative cost savings in the areas of advertising, branding and marketing, legal and professional fees, registration and filing fees, equipment rentals, and business travel. Further, a consulting expense for marketing and sales efforts in the form of stock-based compensation totaled $120,000 during the quarter versus nil in the same period last year. As we did not generate any revenues during the three months ended June 30, 2016, our net loss equaled our operating expenses.

 

For the nine months ended June 30th, 2016 versus June 30th, 2015

 

Revenue

 

The Company recognized $58,556 in revenue from the sale of IHO Bio fertilizer product during the nine months ended June 30, 2016, comparable with $2,397 sales from the same period last year. This increase was mainly due to a significant sale of IHO Bio fertilizer to a distribution partner.

 

Operating Expenses

 

During the nine months ended June 30, 2016 and 2015, we incurred total operating expenses of $265,946 and $176,581, respectively. This increase was mainly due to streamlining of operations and administrative cost savings in the areas of advertising, branding and marketing, legal and professional fees, supplies, business travel, and stock-based compensation. Further, consulting expense for marketing and sales efforts in the form of stock-based compensation totaled $120,000 during the nine months ended June 30,2016 versus 16,426 in the same period last year.

 

Net Loss

 

During the nine months ended June 30, 2016 and 2015, we incurred a net loss of $207,390 and $174,184, respectively. This decrease was mainly due to an increase in the sale of IHO Bio fertilizer, streamlining of operations and administrative cost savings in the areas of advertising, branding and marketing, legal and professional fees, supplies, business travel, and stock-based compensation. Further, consulting expense for marketing and sales efforts in the form of stock-based compensation totaled $120,000 during the nine months ended June 30,2016 versus 16,426 in the same period last year.

 

 10 

 

  

Liquidity and Capital Resources

 

The Company has incurred losses and cumulative negative cash flows from operations through to September 30, 2015 and for the nine months ended June 30, 2016. The Company does not expect to be profitable for the fiscal year ended September 30, 2016. The Company expects that general and administrative expense will continue to increase and, as a result, will need additional capital to fund our operations. The Company intends to finance its operations with cash on hand combined with (i.) an unknown number of proceeds from sales from distribution partners in fiscal 2016; and (ii) proceeds of sale from the Company’s common stock at $0.60 per share on the OTCQB marketplace.

 

We have funded our operations principally from the sale of common stock. As of June 30, 2016, we had $3,313 of cash on hand and $41,225 in receivables. The cost of doing business at the current rate is approximately $14,000 per month. At the current rate, the Company has resources to last until September 2016.

 

The Company’s liquidity will be affected by the following trends; demands, commitments, events or uncertainties; the increase in rent, advertising, testing and certification/license costs, commissions to sales and distribution partners and increase in consulting and professional fees as the company grows. Demands from purchases for open terms or longer credit terms could impact cash flow.

 

Additional funding may not be available on favorable terms, if at all. The Company intends to continue to fund its business by way of equity or debt financing and advances from related parties. In the event we seek to raise additional capital through the issuance of debt or its equivalents, this will result in increased interest expense. If we raise additional capital through the issuance of equity or convertible debt securities, the percentage ownership of our company held by existing shareholders will be reduced and those shareholders may experience significant dilution. In addition, new securities may contain certain rights, preferences or privileges that are senior to those of our common stock. We cannot provide any assurance that we will be able to raise the working capital as needed in the future on terms acceptable to us, if at all.

 

If we are unable to raise capital as needed, we are required to reduce the scope of our business development activities, which could harm our business plans, financial condition and operating results, or cease our operations entirely.

 

Going Concern

 

The Company has only begun to realize revenues and has incurred net losses since inception. In addition, at June 30, 2016, there is an accumulated deficit of $665,609. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

 

There can be no assurance that sufficient funds required during this year or thereafter will be generated from operations or available from external sources such as debt or equity financings, or other potential sources. The inability to generate cash flow from operations or to raise capital from external sources will force the Company to substantially curtail and cease operations, therefore, having a material adverse effect on its business. Furthermore, there can be no assurance that any funds, if available, will possess attractive terms or not have a significant dilutive effect on the Company’s existing stockholders. 

  

Off-Balance Sheet Arrangements

 

The Company has no off-balance sheet arrangements.

  

Inflation

 

We do not believe that inflation has had a material effect on our results of operations.

 

Critical Accounting Policies and Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to select appropriate accounting policies and to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses.

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts or revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Intangible Assets

 

Identifiable intangible assets with indefinite lives are not amortized, but instead are tested for impairment annually, or more frequently if circumstances indicate a possible impairment may exist. Intangible assets with estimable useful lives are amortized over their respective estimated useful lives, generally on a straight-line basis, and are reviewed for impairment whenever events or changes in circumstances indicate that the carrying value may not be recoverable.

  

Share Based Payments

 

The Company recognizes compensation expense for all equity–based payments in accordance with ASC 718 “Share-based payments". Under fair value recognition provisions, the Company recognizes equity–based compensation net of an estimated forfeiture rate and recognizes compensation cost only for those shares expected to vest over the requisite service period of the award.

 

Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on their fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).

 

The Company accounts for share–based payments granted to non–employees in accordance with ASC 505, “Equity Based Payments to Non–Employees”. The Company determines the fair value of the stock–based payment as either the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. If the fair value of the equity instruments issued is used, it is measured using the stock price and other measurement assumptions as of the earlier of either (1) the date at which a commitment for performance by the counterparty to earn the equity instruments is reached, or (2) the date at which the counterparty’s performance is complete.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

We do not hold any derivative instruments and do not engage in any hedging activities.

  

 11 

 

 

ITEM 4. CONTROLS AND PROCEDURES

  

Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports files under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our president (our principal executive officer, principal financial officer and principal accounting officer) to allow for timely decisions regarding required disclosure.

 

At the end of the quarter covered by this report, we carried out an evaluation, under the supervision and with the participation of our president (our principal executive officer, principal financial officer and principal accounting officer) concluded that our disclosure controls and procedures were not effective as of the end of the period covered by this quarterly report.  

  

Changes in Internal Control over Financial Reporting:

 

There were no changes in our internal control over financial reporting during the fiscal quarter ended June 30, 2016, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 12 

 

 

PART II – OTHER INFORMATION

  

ITEM 1. LEGAL PROCEEDINGS

 

We are currently not involved in any litigation that we believe could have a material adverse effect on our financial condition or results of operations. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of our Company or any of our subsidiaries, threatened against or affecting our company, our common stock, any of our subsidiaries or of our companies or our subsidiaries’ officers or directors in their capacities as such, in which an adverse decision could have a material adverse effect.

 

ITEM 1A. RISK FACTORS

 

We believe there are no changes that constitute material changes from the risk factors previously disclosed in our Annual Report on Form 10-K, filed with the SEC on January 13, 2016.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

On April 26, 2016, the Company 400,000 shares of common stock to a consultant for service rendered at a fair value of $120,000 ($0.30/share), based upon the latest cash offer price.

 

The issuance of such securities was exempt from registration pursuant to Section 4(2) of the Securities Act and Regulation D promulgated thereunder.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

There has been no default in the payment of principal, interest, sinking or purchase fund installment, or any other material default, with respect to any indebtedness of the Company.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

There is no other information required to be disclosed under this item which was not previously disclosed.

 

ITEM 6. EXHIBITS

 

Exhibit   Description 
     
31.1   Section 302 Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
     
32.1 *   Section 906 Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
     
101.INS   XBRL Instance
     
101.SCH   XBRL Taxonomy Extension Schema
     
101.CAL    XBRL Taxonomy Extension Calculations
     
101.DEF   XBRL Taxonomy Extension Definitions
     
101.LAB   XBRL Taxonomy Extension Labels
     
101.PRE   XBRL Taxonomy Extension Presentation

 

 

 

* In accordance with SEC Release 33-8238, Exhibit 32.1 is being furnished and not filed.

 

 13 

 

 

SIGNATURES

 

In accordance with to requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

  IHO-Agro International, Inc.  
       
Dated: August 15, 2016 By /s/ Ioan Hossu  
    Ioan Hossu  
    President, Chief Executive Officer, Chief Financial Officer, and Treasurer  

  

 

 14 

EX-31.1 2 v446597_ex31-1.htm EXHIBIT 31.1

Exhibit 31.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

AND PRINCIPAL FINANCIAL OFFICER

PURSUANT TO EXCHANGE ACT RULE 13a-14(a)/15d-14(a)

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

 

I, Ioan Hossu, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of IHO-Agro International, Inc.;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a-15(f) and 15d-15(f)) for the registrant and have:
   
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
   
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
   
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
   
(d)  Disclosed in this report any change in the registrant’s internal control over financing reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
   
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
   
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
   
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. 

 

 

By: /s/ Ioan Hossu  
  Ioan Hossu  
  President, Chief Executive Officer, Chief Financial Officer
  (Principal Executive Officer and Principal Financial Officer)

 

Dated: August 15, 2016

 

 

 

 

EX-32.1 3 v446597_ex32-1.htm EXHIBIT 32.1

 

 Exhibit 32.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

AND PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT of 2002

 

In connection with the Quarterly Report of IHO-Agro International, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Quarterly Report”), Ioan Hossu, Chief Executive Officer and Chief Financial Officer of the Company, certifies, pursuant to 18 U.S.C. section 1350 of the Sarbanes-Oxley Act of 2002, that:

 

1. The Quarterly Report, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
2. The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

By: /s/ Ioan Hossu  
  Ioan Hossu  
  President, Chief Executive Officer, Chief Financial Officer
  (Principal Executive Officer and Principal Financial Officer)

 

Dated: August 15, 2016

 

 

 

 

EX-101.INS 4 cik0001635538-20160630.xml XBRL INSTANCE DOCUMENT 0001635538 2015-04-01 2015-06-30 0001635538 2016-04-01 2016-04-30 0001635538 2016-04-01 2016-06-30 0001635538 2016-04-30 0001635538 2016-06-30 0001635538 2016-08-15 0001635538 2015-09-30 0001635538 2014-10-01 2015-06-30 0001635538 2015-10-01 2016-06-30 0001635538 2014-09-30 0001635538 2015-06-30 0001635538 us-gaap:SalesRevenueNetMember 2015-10-01 2016-06-30 0001635538 us-gaap:AccountsReceivableMember 2015-10-01 2016-06-30 0001635538 us-gaap:AccountsReceivableMember 2014-10-01 2015-09-30 0001635538 us-gaap:ComputerEquipmentMember 2016-06-30 0001635538 us-gaap:ComputerEquipmentMember 2015-09-30 0001635538 us-gaap:MajorityShareholderMember 2016-06-30 0001635538 us-gaap:MajorityShareholderMember 2015-09-30 0001635538 cik0001635538:SoleOfficerAndDirectorMember 2015-10-01 2016-06-30 0001635538 cik0001635538:SoleOfficerAndDirectorMember 2014-07-29 2014-09-30 0001635538 cik0001635538:SoleOfficerAndDirectorMember 2016-06-30 0001635538 cik0001635538:SoleOfficerAndDirectorMember 2015-09-30 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure 3313 33753 41225 11076 50368 70433 94906 115262 1275 1913 96181 117175 31238 6185 3496 3441 714963 550018 -665609 -458219 52850 95240 117175 96181 43331 21935 265946 176581 58556 2397 -207390 -174184 -0.00 -0.01 34529987 33695207 265946 176581 155658 63289 0 2397 -155658 -60892 -0.00 -0.00 35244716 34624878 155658 63289 638 425 -20065 70249 30149 7876 19563 -15781 -80930 -249339 0 2550 0 -2550 45000 42495 50490 42495 -30440 -209394 275984 66590 0 0 0 0 120000 16426 10990 0 62118 0.999 0.856 1 2550 1275 1275 1913 2050 1150 5490 1748 47628 2500 6000 1000 5000 0.05 50368 70433 24000 0 40000000 0.0001 45000 617525 75000 692525 0.6 0.6 0.6 0.5 10-Q false 2016-06-30 2016 Q3 IHO-AGRO INTERNATIONAL INC. 0001635538 --09-30 Smaller Reporting Company 34959002 40000000 0.0001 34959002 34959002 34409002 34409002 12093 15750 -3657 1900 5500 0 Each unit consisted of 10,000 common shares and 5,000 share purchase warrants. <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> A summary of the changes in the Company&#8217;s common share purchase warrants is presented below:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0px:auto; WIDTH: 90%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Number</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Weighted&#160;Average<br/> &#160;Exercise&#160;Price</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Balance September 30, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>617,525</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>0.6</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Issued</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>75,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.6</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Balance June 30, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>692,525</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>0.6</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> As at June 30, 2016, the following common share purchase warrants were outstanding and exercisable:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0px:auto; WIDTH: 90%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>Number&#160;of<br/> &#160;Warrants</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>Exercise&#160;Price</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="56%"> <div>Expiry&#160;Date</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="56%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>692,525</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>$ 0.60</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="56%"> <div>One year from the first day that the Common Stock is traded on the OTCQB marketplace</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> One year from the first day that the Common Stock is traded on the OTCQB marketplace <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0in"></td> <td style="TEXT-ALIGN: left; WIDTH: 0.25in"> <div><font style="FONT-SIZE: 10pt;FONT-FAMILY:Times New Roman, Times, Serif"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>1.</font></div> </td> <td style="TEXT-ALIGN: justify"> <div><font style="FONT-SIZE: 10pt;FONT-FAMILY:Times New Roman, Times, Serif">Basis of Presentation</font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif" align="justify">IHO-Agro International Inc. (the &#8220;Company&#8221;) was incorporated under the laws of the State of Nevada, U.S. on July 29, 2014. The Company&#8217;s principal business is the marketing and distribution of all natural mineral based fertilizers. The Company has limited operations. Since inception through June 30, 2016, the Company has generated $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">62,118</font> in revenue, net, and has accumulated losses of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">665,609</font>.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif" align="justify">The interim unaudited financial statements as of June 30, 2016, and for the three and nine months ended June 30, 2016 and 2015, have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information on the same basis as the annual financial statements and in the opinion of management, reflect all adjustments, which include only normal recurring adjustments necessary to present fairly the Company's financial position, results of operations and cash flows for the periods shown. The results of operations for such periods are not necessarily indicative of the results expected for a full year or for any future period. They do not include all of the information and footnotes required by GAAP for complete financial statements. Therefore, these financial statements should be read in conjunction with the Company's audited financial statements and notes thereto for the year ended September 30, 2015 filed in a Form 10-K.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif" align="justify">During the nine months ended June 30, 2016, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 99.9</font>% of the Company&#8217;s revenue was generated from a single customer. <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 85.6</font>% of the accounts receivable as of June 30, 2016 was from this single customer. <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 100</font>% of the accounts receivable as of September 30, 2015 was from a single customer.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> All fertilizer to fulfill customer orders is manufactured and shipped by a single related party vendor, Industrias y Manufacturas Bionaturales S.A., which is owned by the Company&#8217;s sole officer and sole director.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> Going Concern</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif" align="justify">The financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company has generated minimal revenue since its inception and losses are anticipated in the development of its business. These factors raise substantial doubt about the Company&#8217;s ability to continue as a going concern.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif" align="justify">The ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management intends to finance operating costs over the next twelve months with existing cash on hand, accounts receivables due, and private placement of common stock. Our success is dependent upon commercializing our product and our ability to obtain adequate future financing. There can be no assurance that we will be able to obtain future financing or, if obtained, what the terms of such future financing may be, or that any amount that we are able to obtain will be adequate to support our working capital requirements until we achieve profitable operations. The financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0in"></td> <td style="TEXT-ALIGN: left; WIDTH: 0.25in"> <div><font style="FONT-SIZE: 10pt;FONT-FAMILY:Times New Roman, Times, Serif"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>2.</font></div> </td> <td style="TEXT-ALIGN: justify"> <div><font style="FONT-SIZE: 10pt;FONT-FAMILY:Times New Roman, Times, Serif"> Equipment</font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif" align="justify">Equipment is stated at cost and is depreciated over their estimated useful lives on a three-year straight-line basis.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div style="CLEAR:both;CLEAR: both"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">Cost</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">Accumulated<br/> Depreciation</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">June&#160;30,&#160;2016<br/> &#160;Net&#160;Carrying<br/> &#160;Value</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both"> September&#160;30,&#160;2015&#160;<br/> Net&#160;Carrying<br/> Value</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div style="CLEAR:both;CLEAR: both">Computer Equipment</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">2,550</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">1,275</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">1,275</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">1,913</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div style="CLEAR:both;CLEAR: both"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">Cost</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">Accumulated<br/> Depreciation</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both">June&#160;30,&#160;2016<br/> &#160;Net&#160;Carrying<br/> &#160;Value</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div style="CLEAR:both;CLEAR: both"> September&#160;30,&#160;2015&#160;<br/> Net&#160;Carrying<br/> Value</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div style="CLEAR:both;CLEAR: both">Computer Equipment</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">2,550</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">1,275</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">1,275</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div style="CLEAR:both;CLEAR: both">1,913</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 0px"></td> <td style="WIDTH: 24px"> <div><font style="FONT-SIZE: 10pt;FONT-FAMILY:Times New Roman, Times, Serif"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>3.</font></div> </td> <td> <div><font style="FONT-SIZE: 10pt;FONT-FAMILY:Times New Roman, Times, Serif">Related Party Transactions</font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 24px"> <div>&#160;</div> </td> <td style="WIDTH: 24px; FONT-SIZE: 10pt"> <div><font style="FONT-SIZE: 10pt;FONT-FAMILY:Times New Roman, Times, Serif"> (a)</font></div> </td> <td style="TEXT-ALIGN: justify; FONT-SIZE: 10pt"> <div><font style="FONT-SIZE: 10pt;FONT-FAMILY:Times New Roman, Times, Serif"> Accounts payable as of June 30, 2016 includes $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,050</font> (September 30, 2015 - $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1,150</font>) of rent owed to a shareholder for the offices of the Company.</font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 24px"> <div>&#160;</div> </td> <td style="WIDTH: 24px"> <div><font style="FONT-SIZE: 10pt;FONT-FAMILY:Times New Roman, Times, Serif"> (b)</font></div> </td> <td style="TEXT-ALIGN: justify"> <div><font style="FONT-SIZE: 10pt;FONT-FAMILY:Times New Roman, Times, Serif">As of June 30, 2016, the Company had a balance of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5,490</font> owing to a significant shareholder for a shareholder loan. The loan is unsecured, due on demand and bears no interest.</font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px"> &#160;</div> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 24px"> <div>&#160;</div> </td> <td style="WIDTH: 24px"> <div><font style="FONT-SIZE: 10pt;FONT-FAMILY:Times New Roman, Times, Serif"> (c)</font></div> </td> <td style="TEXT-ALIGN: justify"> <div><font style="FONT-SIZE: 10pt;FONT-FAMILY:Times New Roman, Times, Serif">As of June 30, 2016, the company also had a balance of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1,748</font> owed to another significant shareholder for reimbursement of company expenses paid on its behalf.</font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 24px"> <div>&#160;</div> </td> <td style="WIDTH: 24px; FONT-SIZE: 10pt"> <div><font style="FONT-SIZE: 10pt;FONT-FAMILY:Times New Roman, Times, Serif"> (d)</font></div> </td> <td style="TEXT-ALIGN: justify; FONT-SIZE: 10pt"> <div><font style="FONT-SIZE: 10pt;FONT-FAMILY:Times New Roman, Times, Serif">The Company entered into a management consulting agreement with the Company&#8217;s sole officer and director which commenced on July 29, 2014 for consulting and other services in support of the business operations. Pursuant to the agreement, the Company paid $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,500</font> per month for the first two months and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">6,000</font> per month thereafter. In addition, the Company&#8217;s sole officer and director receives a $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1,000</font> monthly car allowance. As of June 30, 2016, there is a balance of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">24,000</font> (September 30, 2015 - $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0</font>) owed for these services.</font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 24px"> <div>&#160;</div> </td> <td style="WIDTH: 24px; FONT-SIZE: 10pt"> <div><font style="FONT-SIZE: 10pt;FONT-FAMILY:Times New Roman, Times, Serif"> (e)</font></div> </td> <td style="TEXT-ALIGN: justify; FONT-SIZE: 10pt"> <div><font style="FONT-SIZE: 10pt;FONT-FAMILY:Times New Roman, Times, Serif">All fertilizer shipped to customers was manufactured and shipped by a Panamanian entity called Industrias y Manufacturas Bionaturales S.A., which is owned by the Company's sole officer and&#160;director. The Company shall pay Industrias y Manufacturas Bionaturales S.A. a license fee of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5,000</font> per year and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5</font>% of all sub-licensing revenue. The Company makes advance payments to this entity to cover future sales orders. As of June 30, 2016, the aggregate prepaid balance to this related party was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">50,368</font> (September 30, 2015 - $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">70,433</font>), after a $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">47,628</font> reduction for cost of goods sold on sales during the nine months ended June 30, 2016.</font></div> </td> </tr> </table> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="TEXT-ALIGN: left; WIDTH: 0.25in"> <div><font style="FONT-SIZE: 10pt;FONT-FAMILY:Times New Roman, Times, Serif"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>5.</font></div> </td> <td style="TEXT-ALIGN: justify"> <div><font style="FONT-SIZE: 10pt;FONT-FAMILY:Times New Roman, Times, Serif">Share Purchase Warrants</font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> Each Selling Shareholder has a warrant to purchase up to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 50</font>% of the shares owned with an exercise price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.60</font> per shares with the warrant termination on the one-year anniversary of the first day that the Common Stock is traded on the OTCQB marketplace.</div> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>A summary of the changes in the Company&#8217;s common share purchase warrants is presented below:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0px:auto; WIDTH: 90%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Number</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Weighted&#160;Average<br/> &#160;Exercise&#160;Price</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Balance September 30, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>617,525</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>0.6</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Issued</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>75,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.6</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Balance June 30, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>692,525</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>0.6</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> As at June 30, 2016, the following common share purchase warrants were outstanding and exercisable:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0px:auto; WIDTH: 90%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>Number&#160;of<br/> &#160;Warrants</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>Exercise&#160;Price</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="56%"> <div>Expiry&#160;Date</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="56%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>692,525</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>$ 0.60</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="56%"> <div>One year from the first day that the Common Stock is traded on the OTCQB marketplace</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0in"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="TEXT-ALIGN: left; WIDTH: 0.25in"> <div style="CLEAR:both;CLEAR: both"><font style="FONT-SIZE: 10pt;FONT-FAMILY:Times New Roman, Times, Serif"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>4.</font></div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both"><font style="FONT-SIZE: 10pt;FONT-FAMILY:Times New Roman, Times, Serif">Common Stock</font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> The Company has <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 40,000,000</font> common shares authorized with a par value of $ <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0.0001</font> per share.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif" align="justify">In November 2015 and December 2015, the Company issued an aggregate of 15 units for total proceeds of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">45,000</font>. <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Each unit consisted of 10,000 common shares and 5,000 share purchase warrants.</font> Each whole share purchase warrant is exercisable at $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.60</font> per common share until the one-year anniversary of the first day that the common stock is traded on the OTCQB marketplace.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> During the quarter ended June 30, 2016, the Company had the following issuances:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in"></td> <td style="WIDTH: 0.25in"> <div>a)</div> </td> <td> <div>In April 2016, the company issued 400,000 shares of common stock for service valued at 0.30 per common share.</div> </td> </tr> </table> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 400000 0.30 EX-101.SCH 5 cik0001635538-20160630.xsd XBRL TAXONOMY EXTENSION SCHEMA 101 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink 102 - Statement - Balance Sheets link:presentationLink link:definitionLink link:calculationLink 103 - Statement - Balance Sheets [Parenthetical] link:presentationLink link:definitionLink link:calculationLink 104 - Statement - Statements of Operations link:presentationLink link:definitionLink link:calculationLink 105 - Statement - Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 106 - Disclosure - Basis of Presentation link:presentationLink link:definitionLink link:calculationLink 107 - Disclosure - Equipment link:presentationLink link:definitionLink link:calculationLink 108 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 109 - Disclosure - Common Stock link:presentationLink link:definitionLink link:calculationLink 110 - Disclosure - Share Purchase Warrants link:presentationLink link:definitionLink link:calculationLink 111 - Disclosure - Equipment (Tables) link:presentationLink link:definitionLink link:calculationLink 112 - Disclosure - Share Purchase Warrants (Tables) link:presentationLink link:definitionLink link:calculationLink 113 - Disclosure - Basis of Presentation (Details Textual) link:presentationLink link:definitionLink link:calculationLink 114 - Disclosure - Equipment (Details) link:presentationLink link:definitionLink link:calculationLink 115 - Disclosure - Related Party Transactions (Details Textual) link:presentationLink link:definitionLink link:calculationLink 116 - Disclosure - Common Stock (Details Textual) link:presentationLink link:definitionLink link:calculationLink 117 - Disclosure - Share Purchase Warrants (Details) link:presentationLink link:definitionLink link:calculationLink 118 - Disclosure - Share Purchase Warrants (Details 1) link:presentationLink link:definitionLink link:calculationLink 119 - Disclosure - Share Purchase Warrants (Details Textual) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 6 cik0001635538-20160630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 7 cik0001635538-20160630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 8 cik0001635538-20160630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 9 cik0001635538-20160630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 10 R1.htm IDEA: XBRL DOCUMENT v3.5.0.2
Document And Entity Information - shares
9 Months Ended
Jun. 30, 2016
Aug. 15, 2016
Document Information [Line Items]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Jun. 30, 2016  
Document Fiscal Year Focus 2016  
Document Fiscal Period Focus Q3  
Entity Registrant Name IHO-AGRO INTERNATIONAL INC.  
Entity Central Index Key 0001635538  
Current Fiscal Year End Date --09-30  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   34,959,002
XML 11 R2.htm IDEA: XBRL DOCUMENT v3.5.0.2
Balance Sheets - USD ($)
Jun. 30, 2016
Sep. 30, 2015
Current Assets    
Cash $ 3,313 $ 33,753
Accounts receivable 41,225 11,076
Prepaid expenses with related party 50,368 70,433
Total current assets 94,906 115,262
Equipment, net of accumulated depreciation 1,275 1,913
Total Assets 96,181 117,175
LIABILITIES AND STOCKHOLDERS’ EQUITY    
Accounts payable and accrued liabilities 12,093 15,750
Due to shareholders 31,238 6,185
Total Current Liabilities 43,331 21,935
Stockholders’ Equity    
Common stock, 40,000,000 shares authorized, $0.0001 par value, 34,959,002 shares issued and outstanding (September 30, 2015 - 34,409,002 shares) 3,496 3,441
Additional paid-in capital 714,963 550,018
Accumulated deficit (665,609) (458,219)
Total Stockholders’ Equity 52,850 95,240
Total Liabilities and Stockholders’ Equity $ 96,181 $ 117,175
XML 12 R3.htm IDEA: XBRL DOCUMENT v3.5.0.2
Balance Sheets [Parenthetical] - $ / shares
Jun. 30, 2016
Sep. 30, 2015
Common Stock, Shares Authorized 40,000,000 40,000,000
Common Stock, Par or Stated Value Per Share $ 0.0001 $ 0.0001
Common Stock, Shares, Issued 34,959,002 34,409,002
Common Stock, Shares, Outstanding 34,959,002 34,409,002
XML 13 R4.htm IDEA: XBRL DOCUMENT v3.5.0.2
Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Revenue, net $ 0 $ 2,397 $ 58,556 $ 2,397
Operating Expenses:        
General and administrative 155,658 63,289 265,946 176,581
Total Operating Expenses 155,658 63,289 265,946 176,581
Net Loss $ (155,658) $ (60,892) $ (207,390) $ (174,184)
Net Loss Per Share, Basic and Diluted $ (0.00) $ (0.00) $ (0.00) $ (0.01)
Weighted Average Shares Outstanding, Basic and Diluted 35,244,716 34,624,878 34,529,987 33,695,207
XML 14 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
Statements of Cash Flows - USD ($)
9 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Operating Activities    
Net loss $ (207,390) $ (174,184)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 638 425
Stock-based compensation 120,000 16,426
Changes in operating assets and liabilities    
Prepaid expenses with related party 20,065 (70,249)
Accounts receivable (30,149) (7,876)
Accounts payable and accrued liabilities (3,657) 1,900
Due to shareholder 19,563 (15,781)
Net Cash Used In Operating Activities (80,930) (249,339)
Investing Activities    
Purchase of equipment 0 (2,550)
Net Cash Used In Investing Activities 0 (2,550)
Financing Activities    
Proceeds from note payable to related party 10,990 0
Payments on note payable to related party (5,500) 0
Proceeds from common stock issued or subscribed 45,000 42,495
Net Cash Provided By Financing Activities 50,490 42,495
Net Increase (Decrease) in Cash (30,440) (209,394)
Cash, Beginning of Period 33,753 275,984
Cash, End of Period 3,313 66,590
Supplemental Disclosures:    
Interest paid 0 0
Income taxes paid $ 0 $ 0
XML 15 R6.htm IDEA: XBRL DOCUMENT v3.5.0.2
Basis of Presentation
9 Months Ended
Jun. 30, 2016
Organization and Going Concern [Abstract]  
Organization and Going Concern [Text Block]
1.
Basis of Presentation
 
IHO-Agro International Inc. (the “Company”) was incorporated under the laws of the State of Nevada, U.S. on July 29, 2014. The Company’s principal business is the marketing and distribution of all natural mineral based fertilizers. The Company has limited operations. Since inception through June 30, 2016, the Company has generated $62,118 in revenue, net, and has accumulated losses of $665,609.
 
The interim unaudited financial statements as of June 30, 2016, and for the three and nine months ended June 30, 2016 and 2015, have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information on the same basis as the annual financial statements and in the opinion of management, reflect all adjustments, which include only normal recurring adjustments necessary to present fairly the Company's financial position, results of operations and cash flows for the periods shown. The results of operations for such periods are not necessarily indicative of the results expected for a full year or for any future period. They do not include all of the information and footnotes required by GAAP for complete financial statements. Therefore, these financial statements should be read in conjunction with the Company's audited financial statements and notes thereto for the year ended September 30, 2015 filed in a Form 10-K.
 
During the nine months ended June 30, 2016, 99.9% of the Company’s revenue was generated from a single customer. 85.6% of the accounts receivable as of June 30, 2016 was from this single customer. 100% of the accounts receivable as of September 30, 2015 was from a single customer.
 
All fertilizer to fulfill customer orders is manufactured and shipped by a single related party vendor, Industrias y Manufacturas Bionaturales S.A., which is owned by the Company’s sole officer and sole director.
 
Going Concern
 
The financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company has generated minimal revenue since its inception and losses are anticipated in the development of its business. These factors raise substantial doubt about the Company’s ability to continue as a going concern.
 
The ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management intends to finance operating costs over the next twelve months with existing cash on hand, accounts receivables due, and private placement of common stock. Our success is dependent upon commercializing our product and our ability to obtain adequate future financing. There can be no assurance that we will be able to obtain future financing or, if obtained, what the terms of such future financing may be, or that any amount that we are able to obtain will be adequate to support our working capital requirements until we achieve profitable operations. The financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern.
XML 16 R7.htm IDEA: XBRL DOCUMENT v3.5.0.2
Equipment
9 Months Ended
Jun. 30, 2016
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment Disclosure [Text Block]
2.
Equipment
 
Equipment is stated at cost and is depreciated over their estimated useful lives on a three-year straight-line basis.
 
 
 
Cost
 
Accumulated
Depreciation
 
June 30, 2016
 Net Carrying
 Value
 
September 30, 2015 
Net Carrying
Value
 
Computer Equipment
 
$
2,550
 
$
1,275
 
$
1,275
 
$
1,913
 
XML 17 R8.htm IDEA: XBRL DOCUMENT v3.5.0.2
Related Party Transactions
9 Months Ended
Jun. 30, 2016
Related Party Transactions [Abstract]  
Related Party Transactions Disclosure [Text Block]
3.
Related Party Transactions
 
 
 
(a)
Accounts payable as of June 30, 2016 includes $2,050 (September 30, 2015 - $1,150) of rent owed to a shareholder for the offices of the Company.
 
 
(b)
As of June 30, 2016, the Company had a balance of $5,490 owing to a significant shareholder for a shareholder loan. The loan is unsecured, due on demand and bears no interest.
 
 
(c)
As of June 30, 2016, the company also had a balance of $1,748 owed to another significant shareholder for reimbursement of company expenses paid on its behalf.
 
 
(d)
The Company entered into a management consulting agreement with the Company’s sole officer and director which commenced on July 29, 2014 for consulting and other services in support of the business operations. Pursuant to the agreement, the Company paid $2,500 per month for the first two months and $6,000 per month thereafter. In addition, the Company’s sole officer and director receives a $1,000 monthly car allowance. As of June 30, 2016, there is a balance of $24,000 (September 30, 2015 - $0) owed for these services.
 
 
(e)
All fertilizer shipped to customers was manufactured and shipped by a Panamanian entity called Industrias y Manufacturas Bionaturales S.A., which is owned by the Company's sole officer and director. The Company shall pay Industrias y Manufacturas Bionaturales S.A. a license fee of $5,000 per year and 5% of all sub-licensing revenue. The Company makes advance payments to this entity to cover future sales orders. As of June 30, 2016, the aggregate prepaid balance to this related party was $50,368 (September 30, 2015 - $70,433), after a $47,628 reduction for cost of goods sold on sales during the nine months ended June 30, 2016.
XML 18 R9.htm IDEA: XBRL DOCUMENT v3.5.0.2
Common Stock
9 Months Ended
Jun. 30, 2016
Equity [Abstract]  
Stockholders' Equity Note Disclosure [Text Block]
4.
Common Stock
 
The Company has 40,000,000 common shares authorized with a par value of $ 0.0001 per share.
 
In November 2015 and December 2015, the Company issued an aggregate of 15 units for total proceeds of $45,000. Each unit consisted of 10,000 common shares and 5,000 share purchase warrants. Each whole share purchase warrant is exercisable at $0.60 per common share until the one-year anniversary of the first day that the common stock is traded on the OTCQB marketplace.
 
During the quarter ended June 30, 2016, the Company had the following issuances:
 
a)
In April 2016, the company issued 400,000 shares of common stock for service valued at 0.30 per common share.
XML 19 R10.htm IDEA: XBRL DOCUMENT v3.5.0.2
Share Purchase Warrants
9 Months Ended
Jun. 30, 2016
Equity [Abstract]  
Stockholders Equity Note Warrants Or Rights Disclosure [Text Block]
5.
Share Purchase Warrants
 
Each Selling Shareholder has a warrant to purchase up to 50% of the shares owned with an exercise price of $0.60 per shares with the warrant termination on the one-year anniversary of the first day that the Common Stock is traded on the OTCQB marketplace.
 
A summary of the changes in the Company’s common share purchase warrants is presented below:
 
 
 
Number
 
Weighted Average
 Exercise Price
 
Balance September 30, 2015
 
 
617,525
 
$
0.6
 
Issued
 
 
75,000
 
 
0.6
 
Balance June 30, 2016
 
 
692,525
 
$
0.6
 
 
As at June 30, 2016, the following common share purchase warrants were outstanding and exercisable:
 
Number of
 Warrants
 
 
Exercise Price
 
Expiry Date
 
 
 
 
 
 
 
 
692,525
 
 
$ 0.60
 
One year from the first day that the Common Stock is traded on the OTCQB marketplace
 
XML 20 R11.htm IDEA: XBRL DOCUMENT v3.5.0.2
Equipment (Tables)
9 Months Ended
Jun. 30, 2016
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment [Table Text Block]
 
 
 
Cost
 
Accumulated
Depreciation
 
June 30, 2016
 Net Carrying
 Value
 
September 30, 2015 
Net Carrying
Value
 
Computer Equipment
 
$
2,550
 
$
1,275
 
$
1,275
 
$
1,913
 
XML 21 R12.htm IDEA: XBRL DOCUMENT v3.5.0.2
Share Purchase Warrants (Tables)
9 Months Ended
Jun. 30, 2016
Equity [Abstract]  
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
A summary of the changes in the Company’s common share purchase warrants is presented below:
 
 
 
Number
 
Weighted Average
 Exercise Price
 
Balance September 30, 2015
 
 
617,525
 
$
0.6
 
Issued
 
 
75,000
 
 
0.6
 
Balance June 30, 2016
 
 
692,525
 
$
0.6
 
 
As at June 30, 2016, the following common share purchase warrants were outstanding and exercisable:
 
Number of
 Warrants
 
 
Exercise Price
 
Expiry Date
 
 
 
 
 
 
 
 
692,525
 
 
$ 0.60
 
One year from the first day that the Common Stock is traded on the OTCQB marketplace
 
XML 22 R13.htm IDEA: XBRL DOCUMENT v3.5.0.2
Basis of Presentation (Details Textual) - USD ($)
9 Months Ended 12 Months Ended
Jun. 30, 2016
Sep. 30, 2015
Organization and Going Concern [Line Items]    
Retained Earnings (Accumulated Deficit), Total $ (665,609) $ (458,219)
Retained Earnings, Unappropriated $ 62,118  
Sales Revenue, Net [Member]    
Organization and Going Concern [Line Items]    
Concentration Risk, Percentage 99.90%  
Accounts Receivable [Member]    
Organization and Going Concern [Line Items]    
Concentration Risk, Percentage 85.60% 100.00%
XML 23 R14.htm IDEA: XBRL DOCUMENT v3.5.0.2
Equipment (Details) - USD ($)
Jun. 30, 2016
Sep. 30, 2015
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Net $ 1,275 $ 1,913
Computer Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Gross 2,550  
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 1,275  
Property, Plant and Equipment, Net $ 1,275 $ 1,913
XML 24 R15.htm IDEA: XBRL DOCUMENT v3.5.0.2
Related Party Transactions (Details Textual) - USD ($)
2 Months Ended 9 Months Ended
Sep. 30, 2014
Jun. 30, 2016
Sep. 30, 2015
Related Party Transaction [Line Items]      
Due to Related Parties, Current   $ 31,238 $ 6,185
Prepaid Expense, Current   50,368 70,433
Sole Officer and Director [Member]      
Related Party Transaction [Line Items]      
Consulting And Other Services Fees Per Month $ 2,500 6,000  
Car Allowance to Related Parties Per Month   1,000  
License Costs   $ 5,000  
Sub Licensing Revenue Percentage   5.00%  
Prepaid Expense, Current   $ 50,368 70,433
Accrued Liabilities, Current   24,000 0
Cost of Goods Sold, Depreciation   47,628  
Shareholder [Member]      
Related Party Transaction [Line Items]      
Accounts Payable, Current, Total   2,050 1,150
Due to Related Parties, Current   $ 5,490 $ 1,748
XML 25 R16.htm IDEA: XBRL DOCUMENT v3.5.0.2
Common Stock (Details Textual) - USD ($)
1 Months Ended 9 Months Ended
Apr. 30, 2016
Jun. 30, 2016
Sep. 30, 2015
Class of Stock [Line Items]      
Common Stock, Shares Authorized   40,000,000 40,000,000
Common Stock, Par or Stated Value Per Share   $ 0.0001 $ 0.0001
Stock Issued During Period, Value, New Issues   $ 45,000  
Class of Warrant or Right, Exercise Price of Warrants or Rights   $ 0.6 $ 0.6
Shares Issued, Price Per Share $ 0.30    
Stock Issued During Period, Shares, Issued for Services 400,000    
Unit Description   Each unit consisted of 10,000 common shares and 5,000 share purchase warrants.  
XML 26 R17.htm IDEA: XBRL DOCUMENT v3.5.0.2
Share Purchase Warrants (Details)
9 Months Ended
Jun. 30, 2016
$ / shares
shares
Class of Warrant or Right [Line Items]  
Balance, Number | shares 617,525
Issued, Number | shares 75,000
Balance, Number | shares 692,525
Balance, Weighted Average Exercise Price | $ / shares $ 0.6
Issued, Weighted Average Exercise Price | $ / shares 0.6
Balance, Weighted Average Exercise Price | $ / shares $ 0.6
XML 27 R18.htm IDEA: XBRL DOCUMENT v3.5.0.2
Share Purchase Warrants (Details 1) - $ / shares
9 Months Ended
Jun. 30, 2016
Sep. 30, 2015
Class of Warrant or Right [Line Items]    
Number of Warrants 692,525 617,525
Exercise Price $ 0.6 $ 0.6
Expiry Date One year from the first day that the Common Stock is traded on the OTCQB marketplace  
XML 28 R19.htm IDEA: XBRL DOCUMENT v3.5.0.2
Share Purchase Warrants (Details Textual) - $ / shares
9 Months Ended
Jun. 30, 2016
Sep. 30, 2015
Class of Warrant or Right [Line Items]    
Maximum Percentage Of Warrant To Purchase Shares Owned 50.00%  
Class of Warrant or Right, Exercise Price of Warrants or Rights $ 0.6 $ 0.6
EXCEL 29 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 31 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 33 FilingSummary.xml IDEA: XBRL DOCUMENT 3.5.0.2 html 22 78 1 false 5 0 false 4 false false R1.htm 101 - Document - Document And Entity Information Sheet http://www.ihoagrointernationalinc.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 102 - Statement - Balance Sheets Sheet http://www.ihoagrointernationalinc.com/role/BalanceSheets Balance Sheets Statements 2 false false R3.htm 103 - Statement - Balance Sheets [Parenthetical] Sheet http://www.ihoagrointernationalinc.com/role/BalanceSheetsParenthetical Balance Sheets [Parenthetical] Statements 3 false false R4.htm 104 - Statement - Statements of Operations Sheet http://www.ihoagrointernationalinc.com/role/StatementsOfOperations Statements of Operations Statements 4 false false R5.htm 105 - Statement - Statements of Cash Flows Sheet http://www.ihoagrointernationalinc.com/role/StatementsOfCashFlows Statements of Cash Flows Statements 5 false false R6.htm 106 - Disclosure - Basis of Presentation Sheet http://www.ihoagrointernationalinc.com/role/BasisOfPresentation Basis of Presentation Notes 6 false false R7.htm 107 - Disclosure - Equipment Sheet http://www.ihoagrointernationalinc.com/role/Equipment Equipment Notes 7 false false R8.htm 108 - Disclosure - Related Party Transactions Sheet http://www.ihoagrointernationalinc.com/role/RelatedPartyTransactions Related Party Transactions Notes 8 false false R9.htm 109 - Disclosure - Common Stock Sheet http://www.ihoagrointernationalinc.com/role/CommonStock Common Stock Notes 9 false false R10.htm 110 - Disclosure - Share Purchase Warrants Sheet http://www.ihoagrointernationalinc.com/role/SharePurchaseWarrants Share Purchase Warrants Notes 10 false false R11.htm 111 - Disclosure - Equipment (Tables) Sheet http://www.ihoagrointernationalinc.com/role/EquipmentTables Equipment (Tables) Tables http://www.ihoagrointernationalinc.com/role/Equipment 11 false false R12.htm 112 - Disclosure - Share Purchase Warrants (Tables) Sheet http://www.ihoagrointernationalinc.com/role/SharePurchaseWarrantsTables Share Purchase Warrants (Tables) Tables http://www.ihoagrointernationalinc.com/role/SharePurchaseWarrants 12 false false R13.htm 113 - Disclosure - Basis of Presentation (Details Textual) Sheet http://www.ihoagrointernationalinc.com/role/BasisOfPresentationDetailsTextual Basis of Presentation (Details Textual) Details http://www.ihoagrointernationalinc.com/role/BasisOfPresentation 13 false false R14.htm 114 - Disclosure - Equipment (Details) Sheet http://www.ihoagrointernationalinc.com/role/EquipmentDetails Equipment (Details) Details http://www.ihoagrointernationalinc.com/role/EquipmentTables 14 false false R15.htm 115 - Disclosure - Related Party Transactions (Details Textual) Sheet http://www.ihoagrointernationalinc.com/role/RelatedPartyTransactionsDetailsTextual Related Party Transactions (Details Textual) Details http://www.ihoagrointernationalinc.com/role/RelatedPartyTransactions 15 false false R16.htm 116 - Disclosure - Common Stock (Details Textual) Sheet http://www.ihoagrointernationalinc.com/role/CommonStockDetailsTextual Common Stock (Details Textual) Details http://www.ihoagrointernationalinc.com/role/CommonStock 16 false false R17.htm 117 - Disclosure - Share Purchase Warrants (Details) Sheet http://www.ihoagrointernationalinc.com/role/SharePurchaseWarrantsDetails Share Purchase Warrants (Details) Details http://www.ihoagrointernationalinc.com/role/SharePurchaseWarrantsTables 17 false false R18.htm 118 - Disclosure - Share Purchase Warrants (Details 1) Sheet http://www.ihoagrointernationalinc.com/role/SharePurchaseWarrantsDetails1 Share Purchase Warrants (Details 1) Details http://www.ihoagrointernationalinc.com/role/SharePurchaseWarrantsTables 18 false false R19.htm 119 - Disclosure - Share Purchase Warrants (Details Textual) Sheet http://www.ihoagrointernationalinc.com/role/SharePurchaseWarrantsDetailsTextual Share Purchase Warrants (Details Textual) Details http://www.ihoagrointernationalinc.com/role/SharePurchaseWarrantsTables 19 false false All Reports Book All Reports cik0001635538-20160630.xml cik0001635538-20160630.xsd cik0001635538-20160630_cal.xml cik0001635538-20160630_def.xml cik0001635538-20160630_lab.xml cik0001635538-20160630_pre.xml true true ZIP 35 0001144204-16-119324-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001144204-16-119324-xbrl.zip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end